Ira Pastor received his MBA from Temple University and his Bachelor of Science in Pharmacy from Rutgers University. He has over 30 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail. Currently he is the Chief Executive Officer of Bioquark Inc. a company that focuses on the developments of novel combinatorial biologics.

Learning Points:

What are Combinatorial Biologics?

Where has the pharmaceutical industry gone wrong?

How can biologics impact cancer and CNS injury and pathology?

https://www.radiomaria.ca/the-health-hub/